SG Americas Securities
SQZ

SG Americas Securities’s SQZ Biotechnologies Company SQZ Stock Holding History

SG Americas Securities’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43,420
Closed -$12K – 3329
2023
Q2 		$12K Hold
43,420
– – ﹤0.01% 2192
2023
Q1 		$24K Buy
43,420
+27,423
+171% +$20.2K ﹤0.01% 3144
2022
Q4 		$12K Hold
15,997
– – ﹤0.01% 2966
2022
Q3 		$36K Buy
15,997
+200
+1% +$600 ﹤0.01% 3042
2022
Q2 		$50K Sell
15,797
-4,548
-22% -$16.4K ﹤0.01% 3264
2022
Q1 		$98K Sell
20,345
-1,284
-6% -$8.15K ﹤0.01% 2775
2021
Q4 		$193K Sell
21,629
-15,907
-42% -$195K ﹤0.01% 2683
2021
Q3 		$541K Sell
37,536
-4,997
-12% -$67.7K ﹤0.01% 2423
2021
Q2 		$615K Buy
42,533
+2,078
+5% +$27.1K ﹤0.01% 1851
2021
Q1 		$553K Buy
40,455
+25,414
+169% +$516K ﹤0.01% 1958
2020
Q4 		$436K Buy
+15,041
New +$384K ﹤0.01% 2075

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

SG Americas Securities's SQZ Position: Q3 2023 in Review

SG Americas Securities sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 43,420 shares — an estimated $12K sold.

SG Americas Securities first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $615K in Q2 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • SG Americas Securities reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • SG Americas Securities sold 43,420 SQZ Biotechnologies Company shares in Q3 2023, an estimated $12K.
  • SG Americas Securities first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
  • SG Americas Securities's SQZ Biotechnologies Company position peaked at $615K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on SG Americas Securities's 13F filing for Q3 2023, filed 13 Oct 2023.